Interest in immunological mechanisms in the pathogenesis of rheumatoid arthritis has largely concerned serological markers such as rheumatoid factor (Franklin et al., 1957) and immune complexes (Rodman et al., 1967; Baumal and Broder, 1968; Kinsella et al., 1969) . More recent evidence has suggested cell mediated immunity to synovial antigens (Bacon et al., 1973) and there have been studies of lymphocyte subpopulations in the blood (Papamichail et al., 1971; Mellbye et al., 1972; Williams et al., 1973; Keith and Currey, 1973; Yu et al., 1974; Clements et al., 1974; Micheli and Bron, 1974; Vernon-Roberts et al., 1974) and synovial fluid of rheumatoid patients (Mellbye et al., 1972; Froland et al., 1973; Winchester et al., 1973; VernonRoberts et al., 1974) . However, there are few published reports on the proportion of T and B lymphocytes in rheumatoid synovium (Abrahamsen et al., 1975; van Boxel and Paget, 1975; Loewi et al., 1975) . We describe the results of such a study which differs from the previous ones in that T and B markers were sought immediately the lymphocytes had been harvested from the synovial tissue by mechanical mincing and gradient centrifugation. In 3 patients the proportion of synovial T-cells was again determined after the lymphocytes had been subjected to trypsinization and 30-hour culture.
Patients
The 21 patients with rheumatoid arthritis whose blood and synovial tissue lymphocytes were studied were under treatment at the Rheumatism Foundation Hospital, Heinola, Finland. 4 were receiving prednisolone at the time but in none did the daily dose exceed 10 mg. Clinical details are given in Table 1 . Blood lymphocytes only were studied in a further 6 patients, none of whom were receiving corticosteroid drugs. The control group consisted of healthy laboratory staff and patients attending the casualty clinic with minor complaints (mean age±SD, 372±118 years). Total leucocyte and differential white cell counts were made from blood taken at operation into EDTA.
Results
Patients with rheumatoid arthritis had a leucocytosis compared with control subjects, but absolute lymphocyte counts were not significantly different in the two groups ( Table 2 ). The percentages and absolute numbers in the peripheral blood of rosette forming cells, surface Ig bearing cells, and Fc receptor bearing cells were also similar in the two groups (Table 3) .
Rheumatoid synovial tissue contained a significantly lower proportion of rosette forming cells than either synovial fluid or blood (Table 4 ). There was no significant difference between serologically positive and serologically negative patients, nor between patients who had received gold therapy within the past 6 months and those who had not (Table 5) .
The low proportion of synovial tissue rosette forming cells was not accompanied by an increase in the percentage of cells bearing B-cell markers and thus more than half of the lymphocytes harvested from rheumatoid synovial tissue appeared to carry neither T nor B lymphocyte markers. Further experiments were carried out to try to determine whether some of these cells might be T lymphocytes which were incapable of forming rosettes because the receptors for SRBC were blocked. 5±12-7 (27) 24-6+10-5 (27) RA synovial fluid 5774±129 (7) P<0-o0
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Number of patients studied in parentheses. tissue lymphocytes (Table 6 ). However, trypsinized cells which had been cultured for 30 hours had regained this ability so that the proportion capable of rosette formation was now higher than that of native cells and of a similar order to that seen in peripheral blood and synovial fluid. In the 2 patients studied the proportion of rosette forming cells in peripheral blood lymphocytes was not increased above initial values by trypsin treatment and culture.
Discussion SRBC ROSETTE FORMATION BY TRYPSIN TREATED LYMPHOCYTES
Lymphocytes were isolated from peripheral blood and synovial tissue of patients with rheumatoid arthritis as described above and SRBC rosettes were prepared from an aliquot (native cells). The remainder of the lymphocytes were incubated for 30 minutes at room temperature with a 0-15 % solution of trypsin (Worthington Biochemicals, 2 x crystallized) in Ca-and Mg-free PBS. The cells were washed three times in Dulbecco's PBS and an aliquot was tested for SRBC rosette formation (trypsin treated cells). The remainder of the cells were incubated in BHK-21 medium supplemented with 10% fetal calf serum, glutamine, penicillin, and streptomycin for 30 hours at 37°C and, after the culture medium had been washed away, tested for rosette forming activity (trypsin treated and cultured cells).
In the 3 patients studied trypsin treatment virtually eliminated the rosette forming ability of synovial The main finding of this study was the unexpectedly low proportion of rosette forming cells in rheumatoid synovial tissue. The relative proportion of lymphocytes bearing T-or B-cell markers in normal synovial tissue is not known; hence it cannot be stated with certainty that the low proportion of T-cells in rheumatoid synovium is abnormal. It is, however, significantly lower than the proportion in rheumatoid synovial fluid.
The most obvious explanation for this finding is that T-cell damage or depletion could occur during harvesting of lymphocytes from synovial tissue, particularly during mincing. However, lymphocytes derived from other synovial tissue specimens treated in an identical manner were more than 95 % viable by Trypan blue exclusion.
Another possibility is that T-cells might be'fettered' in the synovial tissues through attachment to cellbound antigens and therefore not readily released by mincing. If this were the case B-cells might have been expected to be proportionally increased. However, this was not so, instead the low proportion of T-cells was accompanied by an increase in cells with neither T nor B markers.
Thirdly, it is possible that some of the synovial tissue cells without T or B markers are T-cells which are unable to form rosettes for immunological or other reasons. Incubation of normal peripheral blood lymphocytes with rheumatoid synovial fluid blocks the C3 receptor (a B-cell marker) while incubation with normal synovial fluid has a similar though less marked effect (Mellbye et al., 1972) . It is conceivable that some of the cells harvested from rheumatoid synovial tissue were T-cells whose SRBC receptors were made unavailable through attachment of a synovial tissue antigen or antigens to adjacent receptors or in some other but less specific way. T-cell specific antilymphocyte antibodies (Terasaki et al., 1970; Mittal et al., 1970; Lies et al., 1973) should be detected by staining for SIg and are thus unlikely to be the reason.
SRBC receptors can be removed from the cell surface by treatment with trypsin but regenerate when the cells are washed and cultured (Jondal et al., 1972) . In our study the synovial tissue lymphocytes of only 3 patients were treated in this manner but the increase in T lymphocytes suggested that most of the cells which initially had neither T nor B characteristics were in fact T lymphocytes. This accords with the recent report of Loewi et al. (1975) who found that, after trypsin treatment and 4-day culture, up to 94 % ofrheumatoid synovial membrane lymphocytes formed SRBC rosettes. Two other studies (Abrahamsen et al., 1975; van Boxel and Paget, 1975) 
